Drug Type Small molecule drug |
Synonyms Compound 17af(Seattle Children's Research Institute) |
Target- |
Action inhibitors |
Mechanism Mycobacterium tuberculosis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mycobacterium Infections | Preclinical | United States | 03 Jan 2025 |